EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review

Serena Palmeri iD, Jacopo Ferro iD, Valentina Natoli iD, Caterina Matucci-Cerinic iD, Riccardo Papa, Silvia Rosina iD, Stefania Sorrentino, Stefano Volpi iD, Valerio Gaetano Vellone iD, Marco Gattorno iD, Roberta Caorsi iD

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31759 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Serena Palmeri und 10 weiteren Autor:innen. Beteiligte Einrichtung: UOC Rheumatology and Autoinflammatory diseases, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Hauptthemen laut MEDLINE: Interleukin 1 Receptor Antagonist Protein, Castleman Disease, Fever, Thrombocytopenia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TAFRO (thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly) syndrome is a rare, life‐threatening inflammatory condition linked to infections, neoplasms, and idiopathic multicentric Castleman disease. Interleukin (IL)‐6 inhibitors are the primary treatment, but refractory cases require alternatives. This study reports the first two pediatric TAFRO cases successfully treated with anakinra, an IL‐1 receptor antagonist. Both patients had severe, rapidly progressing disease with multiorgan involvement. Anakinra, combined with corticosteroids, led to significant improvement and remission. We provide a literature review of pediatric TAFRO, confirming its rarity and the partial efficacy of IL‐6 inhibitors in many cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin 1 Receptor Antagonist ProteinCastleman DiseaseFeverThrombocytopeniaRenal InsufficiencyHumansMaleChildFemaleAdolescentEdemaChild, Preschool

Stichwörter der Autor:innen

Castleman diseaseTAFROanakinrainterleukin‐1literature reviewpediatric

Substanzen

Interleukin 1 Receptor Antagonist Protein

Autor:innen und Institutionen

  • UOC Rheumatology and Autoinflammatory diseases, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
  • UOC Pathology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • UOC Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa, Genoa, Italy.

ORCID-Profile: Serena Palmeri, Jacopo Ferro, Valentina Natoli, Caterina Matucci-Cerinic, Silvia Rosina, Stefano Volpi, Valerio Gaetano Vellone, Marco Gattorno, Roberta Caorsi

Zitieren

APA

Palmeri, S., Ferro, J., Natoli, V., Matucci-Cerinic, C., Papa, R., Rosina, S., Sorrentino, S., Volpi, S., Vellone, V. G., Gattorno, M., & Caorsi, R. (2025). Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31759

Vancouver

Palmeri S, Ferro J, Natoli V, Matucci-Cerinic C, Papa R, Rosina S, et al. Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31759

BibTeX
@article{Palmeri2025,
  author = {Palmeri, Serena and Ferro, Jacopo and Natoli, Valentina and Matucci-Cerinic, Caterina and Papa, Riccardo and Rosina, Silvia and Sorrentino, Stefania and Volpi, Stefano and Vellone, Valerio Gaetano and Gattorno, Marco and Caorsi, Roberta},
  title = {Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31759}
}
Kostenlos starten →